Data contained demographics, comorbidity, pre-operative blood tests and length of stay (LOS) after surgery, defined as an overnight stay
The FDA's 2024 review found no published human pharmacokinetic study that formally characterized the subcutaneous route, so these amounts are anecdotal rather than an approved clinical protocol
This difference became more evident from 4 weeks to the endpoint of the experiment
The University of Chicago, for example, published an explanation of why it doesn't control high blood pressure or cure cancer
P-glycoprotein substrates: Berberine may inhibit P-gp, potentially increasing levels of drugs transported by this system
Weight loss support : Clinical trials show meaningful weight reductions in many users (in appropriate settings)